Frédéric Perros

12.9k total citations · 2 hit papers
127 papers, 7.8k citations indexed

About

Frédéric Perros is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Frédéric Perros has authored 127 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Pulmonary and Respiratory Medicine, 37 papers in Cardiology and Cardiovascular Medicine and 23 papers in Molecular Biology. Recurrent topics in Frédéric Perros's work include Pulmonary Hypertension Research and Treatments (105 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (21 papers) and Cardiovascular Function and Risk Factors (13 papers). Frédéric Perros is often cited by papers focused on Pulmonary Hypertension Research and Treatments (105 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (21 papers) and Cardiovascular Function and Risk Factors (13 papers). Frédéric Perros collaborates with scholars based in France, United Kingdom and United States. Frédéric Perros's co-authors include Marc Humbert, Peter Dorfmüller, Bart N. Lambrecht, Hamida Hammad, David Montani, Gérald Simonneau, Sylvia Cohen‐Kaminsky, Élie Fadel, Marcello Chieppa and Ronald N. Germain and has published in prestigious journals such as Circulation, Nature Medicine and Journal of the American College of Cardiology.

In The Last Decade

Frédéric Perros

124 papers receiving 7.7k citations

Hit Papers

House dust mite allergen induces asthma via Toll-like rec... 2009 2026 2014 2020 2009 2015 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells
    2009 895 citations Hamida Hammad, Frédéric Perros et al. profile →
  2. Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension
    2015 437 citations Benoît Ranchoux, Fabrice Antigny et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frédéric Perros France 45 5.3k 2.0k 1.7k 1.4k 1.2k 127 7.8k
Christophe Guignabert France 50 6.9k 1.3× 3.1k 1.5× 2.4k 1.4× 813 0.6× 755 0.7× 159 9.1k
Frank Rose Germany 39 2.9k 0.5× 1.3k 0.7× 1.6k 0.9× 459 0.3× 862 0.7× 68 5.1k
Laimute Taraseviciene‐Stewart United States 25 3.5k 0.7× 1.0k 0.5× 1.2k 0.7× 443 0.3× 675 0.6× 37 4.6k
Patricia A. Thistlethwaite United States 42 4.2k 0.8× 3.3k 1.6× 2.2k 1.3× 206 0.1× 693 0.6× 101 8.5k
Nancy A. Noble United States 40 1.3k 0.3× 2.0k 1.0× 3.7k 2.1× 576 0.4× 645 0.6× 81 9.6k
Guy Lesèche France 41 2.3k 0.4× 1.1k 0.6× 2.1k 1.2× 1.6k 1.2× 744 0.6× 125 7.0k
Makiko Ueda Japan 39 1.1k 0.2× 1.9k 0.9× 1.5k 0.9× 1.7k 1.3× 700 0.6× 164 6.5k
Christian Hugo Germany 46 1.3k 0.3× 532 0.3× 2.6k 1.5× 1.3k 0.9× 464 0.4× 156 8.2k
Masayuki Iwano Japan 35 1.4k 0.3× 438 0.2× 3.4k 2.0× 1.2k 0.9× 541 0.5× 138 8.4k
Peter Heeringa Netherlands 52 5.3k 1.0× 377 0.2× 2.3k 1.3× 4.6k 3.4× 1.8k 1.5× 226 10.7k

Countries citing papers authored by Frédéric Perros

Since Specialization
Citations

This map shows the geographic impact of Frédéric Perros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Perros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Perros more than expected).

Fields of papers citing papers by Frédéric Perros

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Perros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Perros. The network helps show where Frédéric Perros may publish in the future.

Co-authorship network of co-authors of Frédéric Perros

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Perros. A scholar is included among the top collaborators of Frédéric Perros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Perros. Frédéric Perros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baxan, Nicoleta, Ali Ashek, J. Tim Marcus, et al.. (2024). Deep phenotyping of unaffected carriers of pathogenicBMPR2variants screened for pulmonary arterial hypertension. European Respiratory Journal. 64(4). 2400442–2400442. 2 indexed citations
2.
Perros, Frédéric, Cédric Chaveroux, & David Montani. (2024). Bridging the species divide: The limits of rat models in capturing human PVOD mechanisms. Pulmonary Circulation. 14(4). e70016–e70016. 2 indexed citations
3.
Khouri, Charles, Xavier Jaïs, Laurent Savale, et al.. (2024). Characteristics and outcomes of patients developing pulmonary hypertension associated with proteasome inhibitors. European Respiratory Journal. 63(6). 2302158–2302158. 7 indexed citations
4.
Bonnet, Damien, Pedro Mendes‐Ferreira, Stéphane Morisset, et al.. (2024). Pulmonary Hypertension Induced by Right Pulmonary Artery Occlusion: Hemodynamic Consequences of Bmpr2 Mutation. Journal of the American Heart Association. 13(14). e034621–e034621. 2 indexed citations
5.
Perros, Frédéric, Étienne-Marie Jutant, Laurent Savale, et al.. (2023). Physiopathologie et traitements de l’hypertension artérielle pulmonaire. médecine/sciences. 39(4). 359–369. 2 indexed citations
6.
Lecocq, Marylène, Stijn E. Verleden, Caroline Bouzin, et al.. (2022). Disruption of GCN2 Pathway Aggravates Vascular and Parenchymal Remodeling during Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 68(3). 326–338. 9 indexed citations
7.
Perros, Frédéric, David Boulate, Tom Kotsimbos, et al.. (2019). Smooth Muscle Phenotype in Idiopathic Pulmonary Hypertension: Hyper-Proliferative but not Cancerous. International Journal of Molecular Sciences. 20(14). 3575–3575. 16 indexed citations
8.
Nickel, Nils, Ke Yuan, Peter Dorfmüller, et al.. (2019). Beyond the Lungs: Systemic Manifestations of Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 201(2). 148–157. 57 indexed citations
9.
Dumas, Sébastien J., Gilles Bru‐Mercier, Audrey Courboulin, et al.. (2018). NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension. Circulation. 137(22). 2371–2389. 80 indexed citations
10.
Ranchoux, Benoît, Fabrice Antigny, Catherine Rücker‐Martin, et al.. (2015). Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension. Circulation. 131(11). 1006–1018. 437 indexed citations breakdown →
11.
Meloche, Jolyane, François Potus, Benoît Ranchoux, et al.. (2015). miR-223 reverses experimental pulmonary arterial hypertension. American Journal of Physiology-Cell Physiology. 309(6). C363–C372. 102 indexed citations
12.
Tu, Ly, Frances S. de Man, Barbara Girerd, et al.. (2012). A Critical Role for p130Cas in the Progression of Pulmonary Hypertension in Humans and Rodents. American Journal of Respiratory and Critical Care Medicine. 186(7). 666–676. 72 indexed citations
13.
Man, Frances S. de, Ly Tu, M. Louis Handoko, et al.. (2012). Dysregulated Renin–Angiotensin–Aldosterone System Contributes to Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 186(8). 780–789. 252 indexed citations
14.
Perros, Frédéric, Sylvia Cohen‐Kaminsky, Natalia Gambaryan, et al.. (2012). Cytotoxic Cells and Granulysin in Pulmonary Arterial Hypertension and Pulmonary Veno-occlusive Disease. American Journal of Respiratory and Critical Care Medicine. 187(2). 189–196. 41 indexed citations
15.
Montani, David, Frédéric Perros, Natalia Gambaryan, et al.. (2011). C-Kit–Positive Cells Accumulate in Remodeled Vessels of Idiopathic Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 184(1). 116–123. 165 indexed citations
16.
Perros, Frédéric, Peter Dorfmüller, David Montani, et al.. (2011). Pulmonary Lymphoid Neogenesis in Idiopathic Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 185(3). 311–321. 10 indexed citations
17.
Perros, Frédéric, David Montani, Peter Dorfmüller, et al.. (2008). Platelet-derived Growth Factor Expression and Function in Idiopathic Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 178(1). 81–88. 357 indexed citations
18.
Sanchez, Olivier, Élisabeth Marcos, Frédéric Perros, et al.. (2007). Role of Endothelium-derived CC Chemokine Ligand 2 in Idiopathic Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 176(10). 1041–1047. 179 indexed citations
19.
Perros, Frédéric, Peter Dorfmüller, Rogério Souza, et al.. (2006). Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension. European Respiratory Journal. 29(5). 937–943. 114 indexed citations
20.
Perros, Frédéric, Peter Dorfmüller, Rogério Souza, et al.. (2006). Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension. European Respiratory Journal. 29(3). 462–468. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christophe Guignabert Breakdown of academic impact, for papers by Frank Rose Breakdown of academic impact, for papers by Laimute Taraseviciene‐Stewart Breakdown of academic impact, for papers by Patricia A. Thistlethwaite Breakdown of academic impact, for papers by Nancy A. Noble Breakdown of academic impact, for papers by Guy Lesèche Breakdown of academic impact, for papers by Makiko Ueda Breakdown of academic impact, for papers by Christian Hugo Breakdown of academic impact, for papers by Masayuki Iwano Breakdown of academic impact, for papers by Peter Heeringa
Rankless by CCL
2026